COVID-19 康复期肺部异常的肺超声演变:一项前瞻性纵向观察性队列研究
在伦敦城市急诊科20周内前瞻性随访24例不同严重程度COVID-19康复患者,每2周行12区肺超声监测。结果显示肺部在20周内显著恢复,不同异常消退速度不同,小的局限性积液在感染后约10周短暂出现达峰,测得的肺部异常可强烈预测行走时自觉气短。
要点
- COVID-19康复期不同肺超声异常消退速度不同,密集B线在急性期后消退,不规则胸膜和胸膜下实变更缓慢。
- 随胸膜呼吸运动分离的宽B线可能提示残留纤维化改变,是更稳定的征象。
- 小的局限性积液在感染后约10周短暂出现并达峰。
核心结论
- 肺超声显示COVID-19肺部在病后20周内显著恢复,各异常消退速度不同,且可区分急性与既往感染。
- 肺超声可作为COVID-19肺病的长期监测工具,避免反复电离辐射暴露。
研究设计与样本
- 前瞻性观察性队列研究,2020年4月至10月共20周,在伦敦一家繁忙的城市急诊科进行。
- 随访24例不同疾病严重程度的COVID-19康复患者,每2周行12区肺超声监测。
- 监测既往描述的COVID-19肺部异常(不规则胸膜、胸膜下实变、B线、小的局限性积液)的患病率变化。
关键影像表现/征象
- 密集B线占据的整个肋间隙在急性期后消退,而不规则胸膜和胸膜下实变消退更缓慢。
- 随胸膜呼吸运动分离的宽B线可能是更稳定的特征,提示残留纤维化改变。
- 小的局限性积液在初始急性期后短暂出现,于感染后约10周达峰。
诊断标准与关键数值
- 12区肺超声监测不规则胸膜、胸膜下实变、B线及小的局限性积液。
- 测得的肺部异常可强烈预测行走时自觉气短。
临床应用与阅片要点
- 肺超声可用于COVID-19康复期长期监测,避免反复电离辐射暴露。
- 肺超声可能有助于区分急性与既往感染。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: SARS-CoV-2 can cause respiratory diseases with various manifestations. However, little is known about its potential for lung recovery. Lung ultrasound has shown characteristic changes during COVID-19 and has proven to be useful for triage, diagnosis, and therapy. This study investigated how the recovery process from COVID-19 respiratory disease can be monitored using 12-zone lung ultrasound.
METHODS: This prospective observational cohort study was conducted in a busy urban emergency department in London, United Kingdom, over a 20-week period between April and October 2020. We followed 24 patients recovering from COVID-19 with varying disease severity using 12-zone lung ultrasound at 2-week intervals and monitored the changes in the prevalence of lung abnormalities previously described in COVID-19 infection (irregular pleura, subpleural consolidation, B-lines, and small localized effusions).
RESULTS: Lung ultrasound showed that the lung recovers significantly over 20 weeks postdisease. Individual lung abnormalities also resolved at different rates. The entire rib space occupied by confluent B-lines wane after the acute phase, whereas irregular pleura and subpleural consolidations resolved more gradually. Separate wide B-lines moving with the pleura during respiration may represent more stable features, indicating residual fibrotic changes. Small, localized effusions appear transiently after the initial acute phase of the disease, peaking at approximately 10 weeks after infection. The measured lung abnormalities were strong predictors of perceived shortness of breath during ambulation.
CONCLUSION: Lung ultrasound can be a useful tool for long-term monitoring of COVID-19 lung disease, avoiding repeated exposure to ionizing radiation, and may distinguish between acute and past infections.
引用
- Burkert, Jarman, Deol, et al. Evolution of Lung Abnormalities on Lung Ultrasound in Recovery From COVID-19 Disease-A Prospective, Longitudinal Observational Cohort Study. J Ultrasound Med. 2022. PMID: 35429016. doi:10.1002/jum.15990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。